The main objective of the National Focal Point is to collect, to produce, to analyze and to provide valid, reliable and comparable data on drugs and drug addiction in Luxembourg. This includes surveillance and research activities.
EMCDDA
The National European Monitoring Centre for Drugs and Drug addiction – Luxembourg Focal Point has been set up in 1994 and implemented within the CRP-Santé in 2000. It operates both at national and international level and is co-financed by the Ministry of Health and the EMCDDA on a contractual basis. Each of the 27 EU Member states (plus Norway and the candidate countries) run a NFP and thus are part of a wider network called REITOX.
National Focal Points are expert centers, constantly developing to meet emerging needs and follow up trends. Common activities of a NFP include coordinating national information networks in order to meet the EMCDDA’s requirements for a core set of data and to edit annual reports on the state of drugs problem at the national level.
For more information please visit the EMCDDA website:
http://www.emcdda.europa.eu/index.cfm
At European level:
The National Focal Point (NFP) provides the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) with reliable and comparable data on the drugs phenomenon in Luxembourg.
The following core issues are part of the NFPs contributions to the annual work programme of the EMCDDA:
- Prevalence and patterns of use among the general population
- Problem drug use
- Treatment demand
- Drug-related deaths and mortality among drug users
- Drug-related infectious diseases
- Crime, markets and supply data
- Public expenditures dedicated to the fight against drugs
- Action on new drugs and emerging trends
At national level:
The priorities of the NFP are the collection and the compilation of any relevant information on drugs and drug addiction. Over the past ten years, the Focal Point has consolidated national and international cooperation networks and allows promoting, initiating and performing research in the field of illicit drug use and its consequences. Surveillance activities rely on a national network and database called RELIS (“Réseau Luxembourgeois d’Information sur les Stupéfiants” – “Luxembourgish Information Network on Drugs”).
Current Team Members :
Function : Scientific Collaborator
Phone : +352 26970-739
Fax : +352 26970-717
Email : celine.diederich@crp-sante.lu
Function : Scientific Collaborator
Phone : +352 26970-749
Fax : +352 26970-717
Email : sofia.lopesdacosta@crp-sante.lu
Function : External expert- Ministry of Health
Email : alain.origer@ms.etat.lu
2009
Statistic bulletin RELIS 2009_french version (448.03 kB)
2008
Summary RELIS report 2008_english version (72.83 kB)
Statistic bulletin RELIS 2008_french version (490.06 kB)
